Akebia Therapeutics: Q3 Earnings Snapshot
In this article:
CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Akebia Therapeutics Inc. (AKBA) on Wednesday reported a loss of $14.5 million in its third quarter.
On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 8 cents.
The kidney disease treatment developer posted revenue of $42 million in the period.
The company's shares closed at $1.09. A year ago, they were trading at 29 cents.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AKBA at https://www.zacks.com/ap/AKBA
